Greenspring Advisors LLC Takes $1.12 Million Position in UnitedHealth Group Incorporated $UNH

04 Jun 2026, 13:07 by Sarita Garza · The Markets Daily

Greenspring Advisors LLC acquired a new stake in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 3,403 shares of the healthcare conglomerate’s stock, valued at approximately $1,123,000.

Several other institutional investors also recently made changes to their positions in UNH. Norges Bank purchased a new stake in UnitedHealth Group during the 4th quarter worth $4,376,167,000. Capital Research Global Investors boosted its position in UnitedHealth Group by 126.9% during the 3rd quarter. Capital Research Global Investors now owns 13,042,049 shares of the healthcare conglomerate’s stock worth $4,503,419,000 after purchasing an additional 7,293,009 shares during the period. Capital World Investors boosted its position in UnitedHealth Group by 18.8% during the 3rd quarter. Capital World Investors now owns 21,766,922 shares of the healthcare conglomerate’s stock worth $7,516,107,000 after purchasing an additional 3,439,182 shares during the period. Capital International Investors boosted its position in UnitedHealth Group by 11.1% in the 3rd quarter. Capital International Investors now owns 17,499,949 shares of the healthcare conglomerate’s stock valued at $6,042,710,000 after buying an additional 1,747,337 shares during the last quarter. Finally, Lone Pine Capital LLC purchased a new position in UnitedHealth Group in the 2nd quarter valued at about $528,273,000. 87.86% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of research firms have weighed in on UNH. Truist Financial upped their price objective on shares of UnitedHealth Group from $395.00 to $440.00 and gave the company a “buy” rating in a research report on Monday. Barclays upped their price objective on shares of UnitedHealth Group from $373.00 to $429.00 and gave the company an “overweight” rating in a research report on Tuesday, May 26th. HC Wainwright set a $492.00 price objective on shares of UnitedHealth Group in a research report on Wednesday, May 27th. Weiss Ratings raised shares of UnitedHealth Group from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Thursday, May 7th. Finally, Wells Fargo & Company upped their target price on shares of UnitedHealth Group from $370.00 to $397.00 and gave the company an “overweight” rating in a research note on Wednesday, April 22nd. One analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $399.50.

View Our Latest Analysis on UNH

Insider Activity at UnitedHealth Group

In related news, CEO Patrick Hugh Conway sold 800 shares of the firm’s stock in a transaction that occurred on Thursday, April 23rd. The shares were sold at an average price of $355.00, for a total transaction of $284,000.00. Following the transaction, the chief executive officer owned 17,805 shares in the company, valued at $6,320,775. This trade represents a 4.30% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 0.28% of the stock is owned by corporate insiders.

UnitedHealth Group Price Performance

Shares of NYSE:UNH opened at $378.07 on Thursday. The firm’s 50 day moving average is $343.02 and its two-hundred day moving average is $322.52. UnitedHealth Group Incorporated has a 52 week low of $234.60 and a 52 week high of $404.15. The firm has a market capitalization of $343.34 billion, a P/E ratio of 28.56, a PEG ratio of 1.63 and a beta of 0.64. The company has a current ratio of 0.80, a quick ratio of 0.80 and a debt-to-equity ratio of 0.69.

UnitedHealth Group (NYSE:UNH – Get Free Report) last announced its quarterly earnings results on Tuesday, April 21st. The healthcare conglomerate reported $7.23 EPS for the quarter, beating the consensus estimate of $6.76 by $0.47. UnitedHealth Group had a net margin of 2.68% and a return on equity of 14.65%. The company had revenue of $111.65 billion for the quarter, compared to analyst estimates of $109.84 billion. During the same quarter last year, the business earned $7.20 earnings per share. UnitedHealth Group’s revenue was up 2.0% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 18.250- EPS. Analysts anticipate that UnitedHealth Group Incorporated will post 18.29 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 23rd. Investors of record on Monday, June 15th will be paid a dividend of $2.32 per share. This is a boost from UnitedHealth Group’s previous quarterly dividend of $2.21. This represents a $9.28 dividend on an annualized basis and a dividend yield of 2.5%. The ex-dividend date is Monday, June 15th. UnitedHealth Group’s dividend payout ratio (DPR) is 66.77%.

UnitedHealth Group News Roundup

Here are the key news stories impacting UnitedHealth Group this week:

Positive Sentiment: UnitedHealth raised its quarterly dividend by 5% to $2.32 per share, signaling continued confidence in cash flow and a commitment to returning capital to shareholders. UnitedHealth Raises Dividend by 5% as Turnaround Efforts Continue
Positive Sentiment: At its annual shareholder meeting, shareholders re-elected the board and approved executive compensation, which suggests broad investor support for management’s current strategy. UnitedHealth Group Updates on Annual Shareholder Meeting, Board Actions
Neutral Sentiment: Industry commentary remains constructive for large HMO operators like UNH, citing aging demographics, stable Medicare premiums, digital healthcare adoption, and M&A opportunities as tailwinds for the sector. 5 HMO Stocks in Focus Amid an Aging U.S. Population, Tech Innovation
Neutral Sentiment: UnitedHealth also issued a standard update on its annual shareholder meeting and board actions, with no major surprise changes disclosed. UnitedHealth Group Updates on Annual Shareholder Meeting, Board Actions
Negative Sentiment: New reports highlight cost pressure and increased managed care scrutiny, which could weigh on margins if medical costs or regulatory oversight intensify. UnitedHealth Faces Cost Pressure As Managed Care Scrutiny Builds
Negative Sentiment: Medicare reimbursement concerns and a Massachusetts lawsuit accusing the company of inflating Medicaid patient risk scores add fresh legal and reimbursement risk to the UNH story. UnitedHealth Lawsuit Raises Fresh Questions On Medicaid Revenue And Investor Risk

UnitedHealth Group Company Profile

(Free Report)

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.